Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
group_5_presentation_3_-_asthma [2016/04/01 23:41] dmellonr |
group_5_presentation_3_-_asthma [2018/01/25 15:18] (current) |
||
|---|---|---|---|
| Line 174: | Line 174: | ||
| Lambrecht, B., Hammad, H. (2015). The Immunology of Asthma. Nature Immunology, 16(1), 45-56. | Lambrecht, B., Hammad, H. (2015). The Immunology of Asthma. Nature Immunology, 16(1), 45-56. | ||
| - | |||
| - | National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma. Expert Panel (Report 3): Guidelines for the Diagnosis and Management of Asthma, Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2007 Aug. Section 2, Definition, Pathophysiology and Pathogenesis of Asthma and Natural History of Asthma. Available from: http://www.ncbi.nlm.nih.gov/books/NBK7223/ | ||
| Pauwels, R. A., Löfdahl, C. G., Postma, D. S., Tattersfield, A. E., O'Byrne, P., Barnes, P. J., & Ullman, A. (1997). Effect of inhaled formoterol and budesonide on exacerbations of asthma. New England Journal of Medicine, 337(20), 1405-1411. | Pauwels, R. A., Löfdahl, C. G., Postma, D. S., Tattersfield, A. E., O'Byrne, P., Barnes, P. J., & Ullman, A. (1997). Effect of inhaled formoterol and budesonide on exacerbations of asthma. New England Journal of Medicine, 337(20), 1405-1411. | ||
